Protolabs to Attend 2026 Cantor Global Technology & Industrial Growth Conference on March 10, 2026
AI Sentiment
Neutral
5/10
as of 03-06-2026 3:40pm EST
Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. Proto Labs uses injection molding, computer numerical control machining, and 3-D printing to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | Maple Plain |
| Market Cap: | 1.1B | IPO Year: | 2011 |
| Target Price: | $53.00 | AVG Volume (30 days): | 203.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.88 | EPS Growth: | 33.33 |
| 52 Week Low/High: | $30.20 - $68.91 | Next Earning Date: | 05-08-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 8.56% | Revenue Growth (next year): | 6.89% |
| P/E Ratio: | 69.19 | Index: | N/A |
| Free Cash Flow: | 59.7M | FCF Growth: | -13.11% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Chief Operations Officer
Avg Cost/Share
$66.46
Shares
5,000
Total Value
$332,315.00
Owned After
25,302
SEC Form 4
Chief Operations Officer
Avg Cost/Share
$60.00
Shares
2,500
Total Value
$150,000.00
Owned After
25,302
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Kenison Michael R. | PRLB | Chief Operations Officer | Feb 17, 2026 | Sell | $66.46 | 5,000 | $332,315.00 | 25,302 | |
| Kenison Michael R. | PRLB | Chief Operations Officer | Feb 6, 2026 | Sell | $60.00 | 2,500 | $150,000.00 | 25,302 |
SEC 8-K filings with transcript text
Feb 6, 2026 · 100% conf.
1D
-0.07%
$67.12
Act: -1.88%
5D
+5.17%
$70.64
Act: +0.52%
20D
+5.22%
$70.68
prlb-202602060001443669FALSE00014436692026-02-062026-02-06
Washington, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d) OF
Date of Report (Date of earliest event reported): February 6, 2026 Proto Labs, Inc. (Exact name of registrant as specified in its charter)
Minnesota001-3543541-1939628 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification Number)
5540 Pioneer Creek Drive Maple Plain, Minnesota 55359 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code:(763) 479-3680
Not Applicable (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, Par Value $0.001 Per SharePRLBNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition.
On February 6, 2026, Proto Labs, Inc. issued a press release announcing its fourth quarter and full year 2025 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.
Item 9.01.Financial Statements and Exhibits.
(d)Exhibits
99.1Press release of Proto Labs, Inc. dated February 6, 2026
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Proto Labs, Inc.
Date:February 6, 2026 By:/s/ Daniel Schumacher Daniel Schumacher Chief Financial Officer
Feb 6, 2026 · 100% conf.
1D
-0.07%
$67.12
Act: -1.88%
5D
+5.17%
$70.64
Act: +0.52%
20D
+5.22%
$70.68
prlb-202602060001443669TRUE00014436692026-02-062026-02-06
Washington, D.C. 20549
Amendment No. 1
PURSUANT TO SECTION 13 OR 15(d) OF
Date of Report (Date of earliest event reported): February 6, 2026 Proto Labs, Inc. (Exact name of registrant as specified in its charter)
Minnesota001-3543541-1939628 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification Number)
5540 Pioneer Creek Drive Maple Plain, Minnesota 55359 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code:(763) 479-3680
Not Applicable (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, Par Value $0.001 Per SharePRLBNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
This Current Report on Form 8-K/A (this “Amendment”) is being filed as an amendment to the Current Report on Form 8-K filed by Proto Labs, Inc. (the “Company”) with the Securities and Exchange Commission (“SEC”) on February 6, 2026 (the “Original Report”). The sole purpose for filing this Amendment is to correct a scrivener’s error in reporting the guidance range for GAAP diluted earnings per share (“EPS”) for the first quarter of 2026 as described in the press release furnished as Exhibit 99.1 to the Original Report (the “Original Exhibit 99.1”). The correct GAAP diluted EPS guidance range for Q1 2026 is $0.18 to $0.26, rather than the guidance range of $0.17 to $0.25 as reported in the Original Exhibit 99.1 (the “Specified Error”). This Amendment supplements the Original Report and should be read in conjunction with the Original Report. No other changes have been made to the Original Report or Original Exhibit 99.1 other than to correct the Specified Error, as described above and reflected below.
Item 2.02.Results of Operations and Financial Condition.
On February 6, 2026, Proto Labs, Inc. issued a press release announcing its fourth quarter and full year 2025 financial results. The information set forth above under the heading “Explanatory Note” is incorporated by reference into this Item 2.02. The information contained in Items 2.02 and 9.01 of this report is being “furnished” and not “filed” with the SEC for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under such section. Furthermore, such information shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, unless specifically identified as being incorporated therein by reference.
Item 9.01.Financial Statements and Exhibits.
(d)Exhibits
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Proto Labs, Inc.
Date:February 6, 2026 By:/s/ Daniel Schumacher Daniel Schumacher Chief Financial Officer
Oct 31, 2025
prlb-202510310001443669FALSE00014436692025-10-312025-10-31
Washington, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d) OF
Date of Report (Date of earliest event reported): October 31, 2025 Proto Labs, Inc. (Exact name of registrant as specified in its charter)
Minnesota001-3543541-1939628 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification Number)
5540 Pioneer Creek Drive Maple Plain, Minnesota 55359 (Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code:(763) 479-3680
Not Applicable (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, Par Value $0.001 Per SharePRLBNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02.Results of Operations and Financial Condition.
On October 31, 2025, Proto Labs, Inc. issued a press release announcing its third quarter 2025 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference.
Item 9.01.Financial Statements and Exhibits.
(d)Exhibits
99.1Press release of Proto Labs, Inc. dated October 31, 2025
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Proto Labs, Inc.
Date:October 31, 2025 By:/s/ Daniel Schumacher Daniel Schumacher Chief Financial Officer
PRLB Breaking Stock News: Dive into PRLB Ticker-Specific Updates for Smart Investing
AI Sentiment
Neutral
5/10
See how PRLB stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "PRLB Proto Labs Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.